Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Datchat Inc. (NASDAQ: DATS) and Sphere 3D Corp. (NASDAQ: ANY) have been recent short squeeze candidates. Sphere 3D has a short percentage that's currently 57% of shares available, while Datchat has one of 10%.
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.